BlackRock’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-2,869,885
| Closed | -$278M | – | 5047 |
|
2019
Q3 | $278M | Buy |
2,869,885
+113,605
| +4% | +$11M | 0.01% | 1149 |
|
2019
Q2 | $282M | Sell |
2,756,280
-186,616
| -6% | -$19.1M | 0.01% | 1165 |
|
2019
Q1 | $335M | Sell |
2,942,896
-163,402
| -5% | -$18.6M | 0.02% | 1030 |
|
2018
Q4 | $122M | Buy |
3,106,298
+75,255
| +2% | +$2.95M | 0.01% | 1661 |
|
2018
Q3 | $165M | Buy |
3,031,043
+161,811
| +6% | +$8.83M | 0.01% | 1611 |
|
2018
Q2 | $237M | Buy |
2,869,232
+229,786
| +9% | +$19M | 0.01% | 1331 |
|
2018
Q1 | $176M | Sell |
2,639,446
-10,812
| -0.4% | -$720K | 0.01% | 1457 |
|
2017
Q4 | $136M | Buy |
2,650,258
+35,801
| +1% | +$1.84M | 0.01% | 1643 |
|
2017
Q3 | $233M | Buy |
2,614,457
+560,723
| +27% | +$50M | 0.01% | 1218 |
|
2017
Q2 | $123M | Buy |
2,053,734
+213,520
| +12% | +$12.8M | 0.01% | 1661 |
|
2017
Q1 | $98.2M | Buy |
1,840,214
+1,824,117
| +11,332% | +$97.3M | 0.01% | 1786 |
|
2016
Q4 | $804K | Buy |
16,097
+3,574
| +29% | +$179K | ﹤0.01% | 1539 |
|
2016
Q3 | $753K | Buy |
12,523
+10,824
| +637% | +$651K | ﹤0.01% | 1575 |
|
2016
Q2 | $87K | Buy |
1,699
+1,202
| +242% | +$61.6K | ﹤0.01% | 2587 |
|
2016
Q1 | $15K | Buy |
497
+327
| +192% | +$9.87K | ﹤0.01% | 2940 |
|
2015
Q4 | $8K | Hold |
170
| – | – | ﹤0.01% | 2976 |
|
2015
Q3 | $7K | Hold |
170
| – | – | ﹤0.01% | 2883 |
|
2015
Q2 | $10K | Sell |
170
-32,807
| -99% | -$1.93M | ﹤0.01% | 2769 |
|
2015
Q1 | $2.56M | Buy |
+32,977
| New | +$2.56M | ﹤0.01% | 1008 |
|